FBR Capital reiterates an Outperform rating on Core Laboratories (NYSE: CLB), raising price target to $149 from $140.

FBR analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE